VWF and COVID-19: For one, ABO peptides, which are expressed on endothelial cells and platelets, can influence susceptibility to thrombosis via interactions with von Willebrand factor and factor VIII [20] and thus can potentially augment the risk of consumptive coagulopathy and thrombotic microangiopathy in patients with COVID-19.